|
1. Abraham E. NF-[kappa] B activation. Critical Care Medicine 28: N100-N104, 2000.
2. Alalwani SM, Sierigk J, Herr C, Pinkenburg O, Gallo R, Vogelmeier C, and Bals R. The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils. European Journal of Immunology 40: 1118-1126, 2010.
3. Amparyup P, Kondo H, Hirono I, Aoki T, and Tassanakajon A. Molecular cloning, genomic organization and recombinant expression of a crustin-like antimicrobial peptide from black tiger shrimp Penaeus monodon. Molecular Immunology 45: 1085-1093, 2008.
4. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, and Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine 29: 1303-1310, 2001.
5. Arbabi S, and Maier RV. Mitogen-activated protein kinases. Critical Care Medicine 30: S74, 2002.
6. Astiz ME, and Rackow EC. Septic shock. The Lancet 351: 1501-1505, 1998.
7. Baeuerle PA, and Henkel T. Function and activation of NF-kappaB in the immune system. Annual Review of Immunology 12: 141-179, 1994.
8. Baldwin Jr AS. The NF-κB and IκB proteins: new discoveries and insights. Annual Review of Immunology 14: 649-681, 1996.
9. Barkett M, and Gilmore TD. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 18: 6910, 1999.
10. Barnes PJ. Nuclear factor-κB. The International Journal of Biochemistry &; Cell Biology 29: 867-870, 1997.
11. Beck GC, Brinkkoetter P, Hanusch C, Schulte J, van Ackern K, van der Woude FJ, and Yard BA. Clinical review: immunomodulatory effects of dopamine in general inflammation. Critical Care 8: 485, 2004.
12. Beyaert R, Cuenda A, Berghe WV, Plaisance S, Lee J, Haegeman G, Cohen P, and Fiers W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. The EMBO journal 15: 1914, 1996.
13. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Critical Care Medicine 24: 163, 1996.
14. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein R, and Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-1655, 1992.
15. Bryksa B, Macdonald L, Patrzykat A, Douglas S, and Mattatall N. A C-terminal glycine suppresses production of pleurocidin as a fusion peptide in Escherichia coli. Protein Expression and Purification 45: 88-98, 2006.
16. Caivano M, and Cohen P. Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1ß in RAW264 macrophages. The Journal of Immunology 164: 3018, 2000.
17. Chan ED, and Riches DWH. IFN-γ+ LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38 mapk in a mouse macrophage cell line. American Journal of Physiology-Cell Physiology 280: C441-C450, 2001.
18. Chen CC, and Wang JK. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Molecular Pharmacology 55: 481, 1999.
19. Chen J-Y, Lin W-J, and Lin T-L. A fish antimicrobial peptide, tilapia hepcidin TH2-3, shows potent antitumor activity against human fibrosarcoma cells. Peptides 30: 1636-1642, 2009a.
20. Chen J-Y, Lin W-J, Wu J-L, Her GM, and Hui C-F. Epinecidin-1 peptide induces apoptosis which enhances antitumor effects in human leukemia U937 cells. Peptides 30: 2365-2373, 2009b.
21. Cobb MH, and Goldsmith EJ. How MAP kinases are regulated. Journal of Biological Chemistry 270: 14843-14846, 1995.
22. Cole AM, Weis P, and Diamond G. Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder. Journal of Biological Chemistry 272: 12008-12013, 1997.
23. Collins T, and Cybulsky MI. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? Journal of Clinical Investigation 107: 255-266, 2001.
24. Conlon JM, Kolodziejek J, and Nowotny N. Antimicrobial peptides from ranid frogs: taxonomic and phylogenetic markers and a potential source of new therapeutic agents. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1696: 1-14, 2004.
25. Csordas A MH. Isolation and structural resolution of a haemoly-tically active polypeptide from the immune secretion of a European toad. Monatshefte für Chemie / Chemical Monthly 101: 182-189, 1970.
26. Deitch EA. Bacterial translocation of the gut flora. The Journal of Trauma 30: S184-189, 1990.
27. Delves PJ, Martin SJ, Burton DR, and Roitt IM. Roitt's essential immunology. Wiley-Blackwell, 2011.
28. Diamond G, Beckloff N, Weinberg A, and Kisich KO. The roles of antimicrobial peptides in innate host defense. Current Pharmaceutical Design 15: 2377-2392, 2009.
29. Falla TJ, Karunaratne DN, and Hancock REW. Mode of action of the antimicrobial peptide indolicidin. Journal of Biological Chemistry 271: 19298-19303, 1996.
30. Furchgott RF, and Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
31. Galvez A, Abriouel H, Lopez RL, and Ben Omar N. Bacteriocin-based strategies for food biopreservation. International Journal of Food Microbiology 120: 51-70, 2007.
32. Gerondakis S, Grumont RJ, and Banerjee A. Regulating B-cell activation and survival in response to TLR signals. Immunology and Cell Biology 85: 471-475, 2007.
33. Glauser MP, Heumann D, Baumgartner JD, and Cohen J. Pathogenesis and potential strategies for prevention and treatment of septic shock: an update. Clinical Infecctious Diseases 18 Suppl 2: S205-216, 1994.
34. Guha M, and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13: 85-94, 2001.
35. Habermann E. Bee and wasp venoms. Science 177: 314-322, 1972.
36. Hancock REW, and Patrzykat A. Clinical development of cationic antimicrobial peptides from natural to novel antibiotics. Current Drug Targets - Infectious Disorders 2: 79-83, 2002.
37. Hancock REW, and Sahl H-G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nature Biotechnology 24: 1551-1557, 2006.
38. Hancock REW, and Scott MG. The role of antimicrobial peptides in animal defenses. Proceedings of the National Academy of Sciences 97: 8856-8861, 2000.
39. Hayden MS, and Ghosh S. Signaling to NF-κB. Genes &; Development 18: 2195-2224, 2004.
40. Hellman J, Loiselle PM, Tehan MM, Allaire JE, Boyle LA, Kurnick JT, Andrews DM, Sik Kim K, and Warren HS. Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum. Infection and Immunity 68: 2566-2572, 2000.
41. Hoffmann JA, Hetru C, and Reichhart J-M. The humoral antibacterial response of Drosophila. FEBS Letters 325: 63-66, 1993.
42. Hsieh J-C, Pan C-Y, and Chen J-Y. Tilapia hepcidin (TH)2-3 as a transgene in transgenic fish enhances resistance to Vibrio vulnificus infection and causes variations in immune-related genes after infection by different bacterial species. Fish &; Shellfish Immunology 29: 430-439, 2010.
43. Huang H-N, Pan C-Y, Rajanbabu V, Chan Y-L, Wu C-J, and Chen J-Y. Modulation of immune responses by the antimicrobial peptide, epinecidin (Epi)-1, and establishment of an Epi-1-based inactivated vaccine. Biomaterials 32: 3627-3636, 2011.
44. Ikemoto S, Sugimura K, Yoshida N, Yasumoto R, Wada S, Yamamoto K, and Kishimoto T. Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines. Urology 55: 951-955, 2000.
45. Jault, and C. Toll-like receptor gene family and TIR-domain adapters in Danio rerio. Molecular Immunology 40: 759-771, 2004.
46. Jenssen H, Hamill P, and Hancock REW. Peptide antimicrobial agents. Clinical Microbiology Reviews 19: 491-511, 2006.
47. Jia X, Patrzykat A, Devlin RH, Ackerman PA, Iwama GK, and Hancock REW. Antimicrobial peptides protect Coho Salmon from Vibrio anguillarum infections. Applied and Environmental Microbiology 66: 1928–1932, 2000.
48. Kamysz W. Are antimicrobial peptides an alternative for conventional antibiotics. Nuclear Medicine 8: 78–86, 2005.
49. Karin M. Signal transduction from cell surface to nucleus in development and disease. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 6: 2581, 1992.
50. Karin M, and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annual Review of Immunology 18: 621-663, 2000.
51. Kim SH, Kim J, and Sharma RP. Inhibition of p38 and ERK MAP kinases blocks endotoxin-induced nitric oxide production and differentially modulates cytokine expression. Pharmacological Research 49: 433-439, 2004.
52. Lahti A, Lähde M, Kankaanranta H, and Moilanen E. Inhibition of extracellular signal-regulated kinase suppresses endotoxin-induced nitric oxide synthesis in mouse macrophages and in human colon epithelial cells. Journal of Pharmacology and Experimental Therapeutics 294: 1188-1194, 2000.
53. Lai Y, and Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends in Immunology 30: 131-141, 2009.
54. Lasa M, Mahtani KR, Finch A, Brewer G, Saklatvala J, and Clark AR. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Molecular and Cellular Biology 20: 4265-4274, 2000.
55. Lee J, and Lee DG. Structure-antimicrobial activity relationship between pleurocidin and its enantiomer. Experimental and Molecular Medicine 40: 370-376, 2008.
56. Lehmann J, Retz M, Sidhu S, Suttmann H, Sell M, Paulsen F, Harder J, Unteregger G, and Stockle M. Antitumor activity of the antimicrobial peptide Magainin II against bladder cancer cell lines. European Urology 50: 141-147, 2006.
57. Li M, Yu DH, and Cai H. The synthetic antimicrobial peptide KLKL5KLK enhances the protection and efficacy of the combined DNA vaccine against Mycobacterium tuberculosis. DNA and Cell Biology 27: 405-413, 2008.
58. Lim SS, Song YM, Jang MH, Kim Y, Hahm K-S, and Shin SY. Effects of two glycine residues in positions 13 and 17 of pleurocidin on structure and bacterial cell selectivity. Protein and Peptide Letters 11: 35-40, 2004.
59. Lin M-C, Lin S-B, Lee S-C, Lin C-C, Hui C-F, and Chen J-Y. Antimicrobial peptide of an anti-Lipopolysaccharide factor modulates of the inflammatory response in RAW264.7 cells. Peptides 31: 1262-1272, 2010.
60. Lin S-B, Fan T-W, Wu J-L, Hui C-F, and Chen J-Y. Immune response and inhibition of bacterial growth by electrotransfer of plasmid DNA containing the antimicrobial peptide, epinecidin-1, into zebrafish muscle. Fish &; Shellfish Immunology 26: 451-458, 2009a.
61. Lin W, Chien Y, Pan C, Lin T, Chen J, Chiu S, and Hui C. Epinecidin-1, an antimicrobial peptide from fish (Epinephelus coioides) which has an antitumor effect like lytic peptides in human fibrosarcoma cells. Peptides 30: 283-290, 2009b.
62. Lin WJ, and Yeh WC. Implication of Toll-like receptor and Tumor necrosis factor [alpha] signaling in septic shock. Shock 24: 206, 2005.
63. Matsuzaki K. Control of cell selectivity of antimicrobial peptides. Biochimica et Biophysica Acta (BBA) - Biomembranes 1788: 1687-1692, 2009.
64. McCuskey RS, Urbaschek R, and Urbaschek B. The microcirculation during endotoxemia. Cardiovascular Research 32: 752-763, 1996.
65. Meijer, and A. Expression analysis of the Toll-like receptor and TIR domain adaptor families of zebrafish. Molecular Immunology 40: 773-783, 2004.
66. Meister M, Lemaitre B, and Hoffmann JA. Antimicrobial peptide defense in Drosophila. Bioessays 19: 1019-1026, 1997.
67. Mookherjee N, Brown KL, Bowdish DM, Doria S, Falsafi R, Hokamp K, Roche FM, Mu R, Doho GH, Pistolic J, Powers JP, Bryan J, Brinkman FS, and Hancock RE. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. The Journal of Immunology 176: 2455-2464, 2006.
68. Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, and Heumann D. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. The Journal of Immunology 167: 3329-3338, 2001.
69. Nijnik A, and Hancock REW. Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections. Emerging Health Threats Journal 2: e1, 2009.
70. Nizet V. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Current Issues in Molecular Biology 8: 11-26, 2006.
71. Old LJ. Tumor necrosis factor (TNF). Science 230: 630-632, 1985.
72. Oren Z, and Shai Y. A class of highly potent antibacterial peptides derived from Pardaxin, a pore‐forming peptide isolated from moses sole fish Pardachirus marmoratus. European Journal of Biochemistry 237: 303-310, 1996.
73. Pan C-Y, Chen J-Y, Cheng Y-SE, Chen C-Y, Ni IH, Sheen J-F, Pan Y-L, and Kuo C-M. Gene expression and localization of the Epinecidin-1 antimicrobial peptide in the grouper (Epinephelus coioides), and its role in protecting fish against pathogenic infection. DNA and Cell Biology 26: 403-413, 2007.
74. Panyutich A, Shi J, Boutz PL, Zhao C, and Ganz T. Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins. Infection and Immunity 65: 978-985, 1997.
75. Peng K-C, Pan C-Y, Chou H-N, and Chen J-Y. Using an improved Tol2 transposon system to produce transgenic zebrafish with epinecidin-1 which enhanced resistance to bacterial infection. Fish &; Shellfish Immunology 28: 905-917, 2010.
76. Peter Chiou P, Khoo J, Bols NC, Douglas S, and Chen TT. Effects of linear cationic α-helical antimicrobial peptides on immune-relevant genes in trout macrophages. Developmental &; Comparative Immunology 30: 797-806, 2006.
77. Pini A, Falciani C, Mantengoli E, Bindi S, Brunetti J, Iozzi S, Rossolini GM, and Bracci L. A novel tetrabranched antimicrobial peptide that neutralizes bacterial Lipopolysaccharide and prevents septic shock in vivo. The FASEB Journal 24: 1015-1022, 2009.
78. Pockley AG. Heat shock proteins as regulators of the immune response. Lancet 362: 469-476, 2003.
79. Raetz CR. Biochemistry of endotoxins. Annual Review of Biochemistry 59: 129-170, 1990.
80. Raetz CRH, and Whitfield C. Lipopolysaccharide endotoxins. Annual Review of Biochemistry 71: 635-700, 2002.
81. Rajanbabu V, and Chen J-Y. The antimicrobial peptide, tilapia hepcidin 2-3, and PMA differentially regulate the protein kinase C isoforms, TNF-α and COX-2, in mouse RAW264.7 macrophages. Peptides 32: 333-341, 2011.
82. Rajanbabu V, Pan CY, Lee SC, Lin WJ, Lin CC, Li CL, and Chen JY. Tilapia Hepcidin 2-3 peptide modulates Lipopolysaccharide-induced cytokines and inhibits Tumor necrosis factor-alpha through Cyclooxygenase-2 and Phosphodiesterase 4D. Journal of Biological Chemistry 285: 30577-30586, 2010.
83. Ramos R, Silva JP, Rodrigues AC, Costa R, Guardao L, Schmitt F, Soares R, Vilanova M, Domingues L, and Gama M. Wound healing activity of the human antimicrobial peptide LL37. Peptides 32: 1469-1476, 2011.
84. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, and Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). JAMA: the Journal of the American Medical Association 273: 117-123, 1995.
85. Rees D, Palmer R, Schulz R, Hodson H, and Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. British Journal of Pharmacology 101: 746, 1990.
86. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zahringer U, Seydel U, Di Padova F, and et al. Bacterial endotoxin: molecular relationships of structure to activity and function. The FASEB Journal 8: 217-225, 1994.
87. Rosenfeld Y, and Shai Y. Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: Role in bacterial resistance and prevention of sepsis. Biochimica et Biophysica Acta (BBA) - Biomembranes 1758: 1513-1522, 2006.
88. Sallusto F, and Lanzavecchia A. The instructive role of dendritic cells on T-cell responses. Arthritis Research &; Therapy 4 Suppl 3: S127-132, 2002.
89. Saravanan R, Mohanram H, Joshi M, Domadia PN, Torres J, Ruedl C, and Bhattacharjya S. Structure, activity and interactions of the cysteine deleted analog of tachyplesin-1 with Lipopolysaccharide micelle: Mechanistic insights into outer-membrane permeabilization and endotoxin neutralization. Biochimica et Biophysica Acta (BBA) - Biomembranes 1818: 1613-1624, 2012.
90. Scott MG, Davidson DJ, Gold MR, Bowdish D, and Hancock REW. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. The Journal of Immunology 169: 3883-3891, 2002.
91. Scott MG, Vreugdenhil AC, Buurman WA, Hancock RE, and Gold MR. Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. The Journal of Immunology 164: 549-553, 2000.
92. Seger R, and Krebs E. The MAPK signaling cascade. The FASEB Journal 9: 726-735, 1995.
93. Somboonwiwat K, Marcos M, Tassanakajon A, Klinbunga S, Aumelas A, Romestand B, Gueguen Y, Boze H, Moulin G, and Bachère E. Recombinant expression and anti-microbial activity of anti-lipopolysaccharide factor (ALF) from the black tiger shrimp Penaeus monodon. Developmental &; Comparative Immunology 29: 841-851, 2005.
94. Steiner H, Hultmark D, Engstrom A, Bennich H, and Boman HG. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 292: 246-248, 1981.
95. Sung W, and Lee D. Pleurocidin-derived antifungal peptides with selective membrane-disruption effect. Biochemical and Biophysical Research Communications 369: 858-861, 2008.
96. Territo MC, Ganz T, Selsted ME, and Lehrer R. Monocyte-chemotactic activity of defensins from human neutrophils. The Journal of Clinical Investigation 84: 2017-2020, 1989.
97. Toke O. Antimicrobial peptides: New candidates in the fight against bacterial infections. Biopolymers 80: 717-735, 2005.
98. Tripathi P, and Aggarwal A. NF-kB transcription factor: a key player in the generation of immune response. Current Science 90: 519, 2006.
99. Ulevitch RJ, and Tobias PS. Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Current Opinion in Immunology 11: 19-22, 1999.
100. Vila E, and Salaices M. Cytokines and vascular reactivity in resistance arteries. American Journal of Physiology-Heart and Circulatory Physiology 288: H1016-H1021, 2005.
101. Wang X, and Quinn PJ. Lipopolysaccharide: Biosynthetic pathway and structure modification. Progress in Lipid Research 49: 97-107, 2010.
102. Weinberg A, Krisanaprakornkit S, and Dale BA. Epithelial antimicrobial peptides: Review and significance for oral applications. Critical Reviews in Oral Biology &; Medicine 9: 399-414, 1998.
103. Wu G, Li X, Deng X, Fan X, Wang S, Shen Z, and Xi T. Protective effects of antimicrobial peptide S-thanatin against endotoxic shock in mice introduced by LPS. Peptides 32: 353-357, 2011.
104. Zanoni I, and Granucci F. Differences in Lipopolysaccharide-induced signaling between conventional dendritic cells and macrophages. Immunobiology 215: 709-712, 2010.
105. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415: 389-395, 2002.
106. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proceedings of the National Academy of Sciences of the United States of America 84: 5449-5453, 1987.
|